Hair loss is
common. Planning
early matters.
A male hair transplant moves healthy follicular units from the donor area at the back of the head into a receding hairline, thinning mid-scalp, or crown. Male hair loss is common, but every stage needs a different plan — at Pure Line, we assess your pattern, donor capacity, and long-term options before recommending any treatment.
Quick answer
A male hair transplant redistributes donor hair; it does not stop ongoing loss of native hair. A responsible plan considers the diagnosis, age, donor capacity, future progression, medical options and realistic coverage.
Why your hair
is falling out.
The honest answer.
Male pattern hair loss — androgenetic alopecia — is primarily influenced by genetics and sensitivity to androgens such as DHT (dihydrotestosterone), a hormone converted from testosterone by an enzyme called 5-alpha reductase. Age, health, medicines, stress and other conditions can also affect shedding or the diagnosis, so not every case of hair loss should be assumed to be androgenetic alopecia.
Hair follicles genetically sensitive to DHT undergo a process called miniaturisation — they progressively shrink, produce thinner and shorter hairs, and eventually stop producing hair entirely. This process can begin as early as puberty and follows a predictable pattern across the scalp.
Understanding your specific position on that spectrum — and whether it is still progressing — is the first thing our medical team determines. Everything else follows from that.
Where are you
on the spectrum?
The Norwood classification describes seven stages of male pattern baldness. Identifying your stage is the starting point for every treatment decision — and honestly, the earlier you identify it, the more options you have.
.webp)
.webp)
.webp)
.webp)
.webp)
.webp)
.webp)
Two paths. One goal.
Keeping what you have —
and restoring what you've lost.
Dr. Demir's approach always begins with the question: what can medical therapy achieve for this patient, before surgery becomes necessary? For many men, combining both approaches yields the best long-term outcome.
Finasteride or dutasteride may be discussed for selected patients after diagnosis and an individual risk-benefit conversation. Formulation, suitability, possible adverse effects and follow-up should be reviewed by a qualified prescribing clinician.
Topical minoxidil is an established option for pattern hair loss. Low-dose oral minoxidil is prescription treatment and off-label in many settings, so suitability and monitoring require an individual medical assessment.
PRP is an autologous adjunct that has been studied in androgenetic alopecia. Protocols and results vary, and it does not replace diagnosis, evidence-based medical options or long-term surgical planning.
Regenera Activa processes small samples of the patient's own scalp tissue into autologous cellular micrografts. It may be discussed for selected early-stage thinning, but the evidence base remains limited and response varies.
For many patients, the most effective long-term outcome comes from combining medical therapies with carefully planned surgical restoration when appropriate. No single treatment is the complete answer.
Medical treatments are discussed only after individual assessment. Suitability, dose, side effects, and follow-up should always be reviewed by a qualified physician.
- Individual follicles extracted with micro-punch technology — no strip, no linear scar
- Donor harvesting possible from scalp, beard, and body when appropriate
- Allows short hairstyles without visible linear scarring
- Faster recovery with fewer post-operative restrictions
- Extraction approach adapted to donor characteristics and long-term planning
- Designed around conservative, donor-conscious restoration principles
Every case is planned individually, with extraction strategy tailored to donor quality, follicle angle, future loss progression, and long-term donor preservation.
- Involves removal of a linear strip from the donor area
- Leaves a linear donor scar that may influence hairstyle flexibility
- Typically associated with longer recovery and increased post-operative discomfort
- May offer higher graft volumes in selected cases
- Less ideal for patients preferring very short hairstyles
Pure Line focuses on FUE because it aligns more closely with our preference for conservative planning, donor preservation, natural healing, and long-term aesthetic flexibility.
Surgery is not always
the right answer.
This is how we decide.
Dr. Demir evaluates every patient as a unique case — not a graft count. A thorough consultation is not a formality at Pure Line; it is the most important appointment you will have. Here is what he considers before making any surgical recommendation.
Recommending surgery to a patient who is not ready — or who has insufficient donor hair for their projected future loss — is something we refuse to do, regardless of the commercial pressure to do otherwise.
Book Your EvaluationThe donor zone must contain sufficient healthy follicles to cover the recipient area — not just now, but accounting for potential future loss. A patient with limited donor hair and extensive projected baldness may not be a safe surgical candidate.
A very young patient experiencing rapid diffuse thinning presents a different risk profile than a 40-year-old with stable recession. Operating prematurely — before the pattern is established — can result in unnatural-looking outcomes as hair loss continues.
Surgery and medical therapy are not mutually exclusive — they work better together. In suitable patients, medical therapy before surgery may help stabilise native hair and support more predictable long-term planning.
Hair calibre, curl pattern, colour contrast with scalp, and skin elasticity all affect both the procedure approach and the visual outcome. Fine, straight, light-coloured hair requires a different strategy than coarse, curly, dark hair.
A hair transplant redistributes existing hair — it does not create new hair. Understanding the ceiling of what can be achieved with your specific donor supply is the foundation of a satisfying result.
When surgery
may be the
right next step.
Not every man experiencing hair loss is a surgical candidate — and that is honest, not discouraging. The patients who achieve the best results are those who meet the right criteria at the right time. If you recognise yourself in the list opposite, a consultation with Dr. Demir is your logical next move.
Check Your Eligibility-
Norwood Stage III or aboveVisible thinning or recession that is affecting your appearance and confidence — and that medical therapy alone is unlikely to reverse.
-
Stable hair loss patternYour hair loss has slowed or plateaued — ideally confirmed with at least 12 months of stability, and ideally while on a maintenance medical protocol.
-
Healthy donor zoneThe back and sides of your scalp contain dense, stable follicles — enough to cover the areas of concern without depleting future reserve.
-
Good overall healthNo uncontrolled medical conditions that would complicate surgery or healing. Blood thinners, autoimmune conditions, and certain medications are reviewed at consultation.
-
Clear, realistic goalsYou understand that a transplant restores — it does not reverse every year of loss. The best candidates approach the procedure as an investment in density and confidence, not a return to 18.
Not sure where
to start?
Send us your photos and our core medical team will review your hair loss stage, donor area, and treatment options — surgical or non-surgical — with an honest view of what is realistically achievable for your case.
Clinical context and evidence
Dr. Mesut Demir, M.D., is the co-founder and medical director of Pure Line. This page describes general clinical considerations; individual suitability, risks, alternatives and expected outcomes require a personal assessment.
Meet Dr. Mesut Demir and view his background →- Male pattern baldness: classification and incidenceSouthern Medical Journal · 1975
- The effectiveness of treatments for androgenetic alopeciaJournal of the American Academy of Dermatology · 2017
- Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic reviewDermatology Reports · 2024
- Efficacy and safety of low-dose oral minoxidil in androgenetic alopeciaExpert Opinion on Pharmacotherapy · 2024
- The role of platelet-rich plasma in androgenetic alopecia: a systematic reviewJournal of Cosmetic Dermatology · 2024
- Short-Term Efficacy of Autologous Cellular Micrografts in Androgenetic AlopeciaClinical, Cosmetic and Investigational Dermatology · 2021
The medical information on this page is provided for educational purposes and does not replace a personal consultation. Treatment suitability can only be determined after an individual assessment.